C.E.Management Integrated LaboratoryLtd Balance Sheet Health
Financial Health criteria checks 5/6
C.E.Management Integrated LaboratoryLtd has a total shareholder equity of ¥4.7B and total debt of ¥549.0M, which brings its debt-to-equity ratio to 11.8%. Its total assets and total liabilities are ¥6.7B and ¥2.0B respectively. C.E.Management Integrated LaboratoryLtd's EBIT is ¥543.3M making its interest coverage ratio -77.1. It has cash and short-term investments of ¥2.1B.
Key information
11.8%
Debt to equity ratio
JP¥548.96m
Debt
| Interest coverage ratio | -77.1x |
| Cash | JP¥2.06b |
| Equity | JP¥4.66b |
| Total liabilities | JP¥2.01b |
| Total assets | JP¥6.67b |
Recent financial health updates
No updates
Recent updates
C.E.Management Integrated LaboratoryLtd's (TSE:6171) Dividend Will Be ¥6.00
Oct 14
C.E.Management Integrated LaboratoryLtd (TSE:6171) Is Due To Pay A Dividend Of ¥6.00
Sep 29C.E.Management Integrated LaboratoryLtd (TSE:6171) Will Pay A Dividend Of ¥6.00
Aug 27We Think You Can Look Beyond C.E.Management Integrated LaboratoryLtd's (TSE:6171) Lackluster Earnings
Mar 30Financial Position Analysis
Short Term Liabilities: 6171's short term assets (¥3.7B) exceed its short term liabilities (¥1.1B).
Long Term Liabilities: 6171's short term assets (¥3.7B) exceed its long term liabilities (¥899.5M).
Debt to Equity History and Analysis
Debt Level: 6171 has more cash than its total debt.
Reducing Debt: 6171's debt to equity ratio has increased from 0% to 11.8% over the past 5 years.
Debt Coverage: 6171's debt is well covered by operating cash flow (129.5%).
Interest Coverage: 6171 earns more interest than it pays, so coverage of interest payments is not a concern.